Coronavac: o que a ciência comprova (versão para crianças e adolescentes)

Abstract

The CoronaVac digital dossier: what the science proves, children and adolescents version, is now available to public health experts, clinicians, researchers and the general public. The material brings together studies and publications from scientific journals of worldwide relevance to prove the effectiveness of CoronaVac, a vaccine against Covid-19 from Butantan and the Chinese pharmaceutical company Sinovac, in children and adolescents.

Bringing nine scientific studies, the dossier is more evidence that proves the importance and need for vaccination of children and adolescents to stop the advance of the Covid-19 pandemic. The research contained in the dossier was published in international publications such as The New England Journal of Medicine, The Lancet, The Lancet Infectious Diseases, Vaccines and PLOS Neglected Tropical Disease, among others.

All topics in the table of contents have an abbreviated introduction in Portuguese and the original publication in English. Among the topics covered are the safety of CoronaVac in the pediatric population, the strong immune response generated by the vaccine in children and adolescents, as well as data on its effectiveness in these populations - that is, the effectiveness of the vaccine in the real world to prevent hospitalizations and deaths.